Costello Asset Management, Inc Bio N Tech Se Transaction History

Costello Asset Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$126.25 - $231.85 $1,893 - $3,477	-15 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$216.64 - $362.52 $7,582 - $12,688	-35 Reduced 70.0%	15 $4,000
Q3 2021 Oct 29, 2021	SELL	$205.93 - $447.23 $10,296 - $22,361	-50 Reduced 50.0%	50 $14,000
Q3 2020 Nov 04, 2020	BUY	$57.81 - $104.17 $5,781 - $10,417	100 New	100 $7,000

325

39.2M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Costello Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Costello Asset Management, Inc with notifications on news.